Natus Medical Inc
NTUS
NTUS was delisted on the 20th of July, 2022.
172 hedge funds and large institutions have $1.04B invested in Natus Medical Inc in 2019 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 70 increasing their positions, 42 reducing their positions, and 14 closing their positions.
67% more repeat investments, than reductions
Existing positions increased: 70 | Existing positions reduced: 42
64% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 14
54% more call options, than puts
Call options by funds: $1.56M | Put options by funds: $1.01M
2% more funds holding
Funds holding: 168 → 172 (+4)
4% more capital invested
Capital invested by funds: $998M → $1.04B (+$37.5M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$10.1M |
| 2 |
Bank of New York Mellon
New York
|
+$9.78M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$7.41M |
| 4 |
Prudential Financial
Newark,
New Jersey
|
+$7.05M |
| 5 |
BlackRock
New York
|
+$5.77M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$37.2M |
| 2 |
SAM
Silvercrest Asset Management
New York
|
-$12M |
| 3 |
SBH
Segall Bryant & Hamill
Chicago,
Illinois
|
-$4.38M |
| 4 |
CRM
Cramer Rosenthal McGlynn
Stamford,
Connecticut
|
-$3.99M |
| 5 |
VCM
Voce Capital Management
San Francisco,
California
|
-$3.68M |
NTUS Hedge Fund Activity: Q4 2019 in Review
172 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Natus Medical Inc (NTUS) for Q4 2019, worth a combined $1.04B — up 3.8% from $998M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new NTUS positions and 14 closed out — a net gain of 9 holders — while 70 added to existing stakes and 42 trimmed.
The largest buyer was Goldman Sachs, adding an estimated $10.1M. The largest seller was Janus Henderson Group, cutting an estimated $37.2M.
- 172 institutional investors held Natus Medical Inc (NTUS) as of Q4 2019, up from 168 in Q3 2019.
- Funds reported $1.04B of Natus Medical Inc stock for Q4 2019, up 3.8% quarter-over-quarter.
- 23 funds opened new Natus Medical Inc positions in Q4 2019 and 14 closed out, a net change of +9 holders.
- The largest Natus Medical Inc buyer in Q4 2019 was Goldman Sachs, an estimated $10.1M added.
- The largest Natus Medical Inc seller in Q4 2019 was Janus Henderson Group, an estimated $37.2M sold.
Based on aggregated 13F filings for Q4 2019.